Mesoblast scores first US nod for mesenchymal stromal cell therapy | BioWorld

back pain,” Itescu said. Mesoblast's two distinct cell therapy products – rexlemestrocel-L and remestemcel-L – are, respectively, being developed …
Source: back pain